by Stem Cell Network | Aug 25, 2010
Right now, you’re seeing this blog post thanks to your cornea. In concert with your eye’s lens, the cornea refracts light and allows you to distinguish the letters on this page from the background. But your cornea is vulnerable to disease — clouding...
by Ubaka Ogbogu | Jul 12, 2010
On June 30, the Canadian Institutes of Health Research (CIHR) released updated Guidelines for Human Pluripotent Stem Cell Research. The Guidelines apply to all research involving human pluripotent stem cells conducted with funding from, or under the auspices of...
by David Kent | Jun 28, 2010
Earlier this month, the New Scientist shook up the stem cell community, putting forth the idea that publication speed, frequency, and journal quality might be skewed by where you’re from and who you know rather than the quality of your data. The article, entitled...
by Ubaka Ogbogu | Jun 24, 2010
NAS revises stem cell guidelines: The US National Academy of Sciences recently released amendments to its influential and widely adopted voluntary Guidelines for Human Embryonic Stem Cell Research. This is the third set of amendments since the guidelines were first...
by Chris Kamel | Jun 14, 2010
Simple diagram that shows the development of different blood cells from hematopoietic stem cell to mature cells. From Wikipedia. All blood cells arise from the common hematopoietic stem cell and are classified into two lineages: lymphoid cells (B-, T- and Natural...
by Katie Moisse | Jun 8, 2010
For centuries, “snake oil salesmen” have used cleverly crafted acts to peddle fake medicines. The modern-day version of the medical conman has zeroed on stem cells, selling treatments with unproven effects and unknown risks. Using online marketing campaigns, stem...
Comments